Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT06259929
Title NEOadjuvant Abemaciclib and GIredestrant triaL in Patients With ER-positive, HER2-negative Early Breast Cancer (Neo-AGILE)
Acronym Neo-AGILE
Recruitment Not yet recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors Fondazione Oncotech
Indications
Therapies
Age Groups: adult | senior
Covered Countries ITA


No variant requirements are available.